← Leaderboards
Richard G Moran
Virginia Commonwealth University
$8,282,680
Attributed
$8,282,680
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $836.4K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$8,282,680 · 4
By mechanism
R01$8,282,680 · 4
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Alexandra Christin Racanelli$613,811
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellFolateAntimetabolitesLaboratory MouseMalignant NeoplasmsCellsResearch StudyBinding (Molecular Function)Active SitesTetrahydrofolatesEventLeadStructureFolic Acid AntagonistsFolic Acid MetabolismBaseMitochondriaEnzymesFeedbackLeukemic CellDesignDrug DevelopmentEnzymatic BiochemistryAnalog
Grant awards (30)
Antifolate activators of AMP-dependent protein kinase$280,918
R01 · FY2014 · CA · contact PI
Human Folylpolyglutamate Synthetase and Cancer Therapeutics$276,939
R01 · FY2014 · CA · contact PI
Antifolate activators of AMP-dependent protein kinase$272,639
R01 · FY2013 · CA · contact PI
Human Folylpolyglutamate Synthetase and Cancer Therapeutics$268,374
R01 · FY2013 · CA · contact PI
Antifolate activators of AMP-dependent protein kinase$290,459
R01 · FY2012 · CA · contact PI
Human Folylpolyglutamate Synthetase and Cancer Therapeutics$285,504
R01 · FY2012 · CA · contact PI
Antifolate activators of AMP-dependent protein kinase$290,861
R01 · FY2011 · CA · contact PI
Human Folylpolyglutamate Synthetase and Cancer Therapeutics$285,504
R01 · FY2011 · CA · contact PI
Human Folylpolyglutamate Synthetase and Cancer Therapeutics$294,178
R01 · FY2010 · CA · contact PI
Antifolate activators of AMP-dependent protein kinase$289,984
R01 · FY2010 · CA · contact PI
NUCLEOTIDE DEPRIVATION-BASED SELECTIVE THERAPEUTICS$281,195
R01 · FY2008 · CA · contact PI
HUMAN MITOCHONDRIAL FOLATE/ANTIFOLATE TRANSPORT$229,814
R01 · FY2008 · CA · contact PI
NUCLEOTIDE DEPRIVATION-BASED SELECTIVE THERAPEUTICS$281,457
R01 · FY2007 · CA · contact PI
HUMAN MITOCHONDRIAL FOLATE/ANTIFOLATE TRANSPORT$230,315
R01 · FY2007 · CA · contact PI
NUCLEOTIDE DEPRIVATION-BASED SELECTIVE THERAPEUTICS$290,123
R01 · FY2006 · CA · contact PI
MECHANISM AND CONTROL OF FOLATE POLYGLUTAMATON$288,971
R01 · FY2006 · CA · contact PI
HUMAN MITOCHONDRIAL FOLATE/ANTIFOLATE TRANSPORT$237,194
R01 · FY2006 · CA · contact PI
NUCLEOTIDE DEPRIVATION-BASED SELECTIVE THERAPEUTICS$297,360
R01 · FY2005 · CA
MECHANISM AND CONTROL OF FOLATE POLYGLUTAMATON$295,925
R01 · FY2005 · CA
HUMAN MITOCHONDRIAL FOLATE/ANTIFOLATE TRANSPORT$243,151
R01 · FY2005 · CA
MECHANISM AND CONTROL OF FOLATE POLYGLUTAMATON$295,925
R01 · FY2004 · CA
HUMAN MITOCHONDRIAL FOLATE/ANTIFOLATE TRANSPORT$290,890
R01 · FY2004 · CA
NUCLEOTIDE DEPRIVATION-BASED SELECTIVE THERAPEUTICS$281,250
R01 · FY2004 · CA
MECHANISM AND CONTROL OF FOLATE POLYGLUTAMATON$295,925
R01 · FY2003 · CA
MOLECULAR BASES OF TETRAHYDROFOLATE ANTIMETABOLISM$296,776
R01 · FY2002 · CA
MECHANISM AND CONTROL OF FOLATE POLYGLUTAMATON$295,925
R01 · FY2002 · CA
MOLECULAR BASES OF TETRAHYDROFOLATE ANTIMETABOLISM$288,133
R01 · FY2001 · CA
CHEMOTHERAPY BASED ON FOLYLPOLYGLUTAMATE SYNTHETASE$226,931
R01 · FY2001 · CA
MOLECULAR BASES OF TETRAHYDROFOLATE ANTIMETABOLISM$279,740
R01 · FY2000 · CA
CHEMOTHERAPY BASED ON FOLYLPOLYGLUTAMATE SYNTHETASE$220,320
R01 · FY2000 · CA